Neuroinflammation-Associated Alterations of the Brain as Potential Neural Biomarkers in Anxiety Disorders
Open accessThe DOI matches its Crossref record; 69 of the 69 references it cites were found in a registry or an index.
Abstract
Stress-induced changes in the immune system, which lead to neuroinflammation and consequent brain alterations, have been suggested as possible neurobiological substrates of anxiety disorders, with previous literature predominantly focusing on panic disorder, agoraphobia, and generalized anxiety disorder, among the anxiety disorders. Anxiety disorders have frequently been associated with chronic stress, with chronically stressful situations being reported to precipitate the onset of anxiety disorders. Also, chronic stress has been reported to lead to hypothalamic–pituitary–adrenal axis and autonomic nervous system disruption, which may in turn induce systemic proinflammatory conditions. Preliminary evidence suggests anxiety disorders are also associated with increased inflammation. Systemic inflammation can access the brain, and enhance pro-inflammatory cytokine levels that have been shown to precipitate direct and indirect neurotoxic effects. Prefrontal and limbic structures are widely reported to be influenced by neuroinflammatory conditions. In concordance with these findings, various imaging studies on panic disorder, agoraphobia, and generalized anxiety disorder have reported alterations in structure, function, and connectivity of prefrontal and limbic structures. Further research is needed on the use of inflammatory markers and brain imaging in the early diagnosis of anxiety disorders, along with the possible efficacy of anti-inflammatory interventions on the prevention and treatment of anxiety disorders.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Vagus nerve stimulation attenuates the systemic inflammatory response to endotoxin
Borovikova, L. V., Ivanova, S., Zhang, M., Yang, H., Botchkina, G. I., Watkins, L. R., Wang, H., Abumrad, N., Eaton, J. W., & Tracey, K. J. (2000) · Nature · doi:10.1038/35013070 · Cited by 4,211
C-reactive protein: a critical update
Pepys, M. B., & Hirschfield, G. M. (2003) · Journal of Clinical Investigation · doi:10.1172/jci200318921 · Cited by 3,436
Nicotinic acetylcholine receptor α7 subunit is an essential regulator of inflammation
Wang, H., Yu, M., Ochani, M., Amella, C. A., Tanovic, M., Susarla, S., Li, J. H., Wang, H., Yang, H., Ulloa, L., et al. (2003) · Nature · doi:10.1038/nature01339 · Cited by 3,228 · cited 2×
“The term “cholinergic anti-inflammatory pathway” was then coined, and subsequent studies established that acetylcholine and nicotine attenuated inflammation by stimulating alpha-7 nicotinic receptors [68].”
BackgroundAntiinflammatory Action of Glucocorticoids — New Mechanisms for Old Drugs
Rhen, T., & Cidlowski, J. A. (2005) · New England Journal of Medicine · doi:10.1056/nejmra050541 · Cited by 3,149 · cited 1×
“Glucocorticoid receptor binding also exerts anti-inflammatory effects by inhibiting nuclear factor kappa B [18].”
BackgroundMeditation Programs for Psychological Stress and Well-being: A Systematic Review and Meta-analysis
Goyal, M., Singh, S., Sibinga, E. M. S., Gould, N. F., Rowland-Seymour, A., Sharma, R., Berger, Z., Sleicher, D., Maron, D. D., Shihab, H. M., et al. (2014) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2013.13018 · Cited by 2,380
Laborde, S., Mosley, E., & Thayer, J. F. (2017) · Frontiers in Psychology · doi:10.3389/fpsyg.2017.00213 · Cited by 2,336
Thayer, J. F., & Lane, R. D. (2009) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2008.08.004 · Cited by 2,040 · cited 1×
“With heart rate variability being considered as an index of the influence of both the sympathetic nervous system and the parasympathetic nervous system [45], high heart rate variability has been reported to reflect increased parasympathetic activity, and low heart rate variability to reflect increased sympathetic acti…”
BackgroundPsychobiotics: A novel class of psychotropic
Dinan, T. G., Stanton, C., & Cryan, J. F. (2013) · Biological Psychiatry · doi:10.1016/j.biopsych.2013.05.001 · Cited by 1,287 · cited 1×
“shown to improve anxiety symptoms and have even been termed as psychobiotics [165].”
BackgroundFries, E., Hesse, J., Hellhammer, J., & Hellhammer, D. H. (2005) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2005.04.006 · Cited by 1,204 · cited 1×
“Hypothalamic-pituitary-adrenal axis negative feedback is also disrupted by the impairment of glucocorticoid receptor binding, and cortisol levels which are normally sufficient are no longer able to inhibit corticotropin-releasing hormone release [23].”
BackgroundAnxiety Disorders are Associated with Reduced Heart Rate Variability: A Meta-Analysis
Chalmers, J. A., Quintana, D. S., Abbott, M. J.-A., & Kemp, A. H. (2014) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2014.00080 · Cited by 1,067 · cited 1×
“Decreased heart rate variability has been observed in patients with generalized anxiety disorder [47], along with a recent meta-analysis concluding anxiety disorders are associated with decreased heart rate variability [48].”
BackgroundJones, B. E., & Yang, T. (1985) · Journal of Comparative Neurology · doi:10.1002/cne.902420105 · Cited by 896
IL-1β is an essential mediator of the antineurogenic and anhedonic effects of stress
Koo, J. W., & Duman, R. S. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0708092105 · Cited by 862 · cited 1×
“Cell proliferation can be decreased through the nuclear factor kappa B signaling pathway by pro-inflammatory cytokines, as nuclear factor kappa B is the primary transcription factor for inflammatory response initiation, and conveys peripheral inflammatory signals to the central nervous system [84,85].”
BackgroundAutonomic characteristics of generalized anxiety disorder and worry
Thayer, J. F., Friedman, B. H., & Borkovec, T. D. (1996) · Biological Psychiatry · doi:10.1016/0006-3223(95)00136-0 · Cited by 857 · cited 1×
“Decreased heart rate variability has been observed in patients with generalized anxiety disorder [47], along with a recent meta-analysis concluding anxiety disorders are associated with decreased heart rate variability [48].”
BackgroundAutonomic innervation and regulation of the immune system (1987–2007)
Nance, D. M., & Sanders, V. M. (2007) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2007.03.008 · Cited by 855
Neuronal ‘On’ and ‘Off’ signals control microglia
Biber, K., Neumann, H., Inoue, K., & Boddeke, H. W. G. M. (2007) · Trends in Neurosciences · doi:10.1016/j.tins.2007.08.007 · Cited by 787 · cited 1×
“Functionally, microglial activation is defined as the release of pro-inflammatory cytokines such as interleukin 1β, tumor necrosis factor α, and interleukin 6 [78].”
BackgroundInflammation in Fear- and Anxiety-Based Disorders: PTSD, GAD, and Beyond
Michopoulos, V., Powers, A., Gillespie, C. F., Ressler, K. J., & Jovanovic, T. (2017) · Neuropsychopharmacology · doi:10.1038/npp.2016.146 · Cited by 786 · cited 2×
“Although findings on inflammation associated with anxiety disorders have not been consistent, which to a certain extent is considered to be due to the wide range of variability among measures and samples, the overall evidence points to anxiety disorders being associated with enhanced inflammation [5].”
BackgroundHair cortisol, stress exposure, and mental health in humans: A systematic review
Staufenbiel, S. M., Penninx, B. W. J. H., Spijker, A. T., Elzinga, B. M., & van Rossum, E. F. C. (2013) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2012.11.015 · Cited by 736 · cited 1×
“Elevated hair and salivary cortisol levels have been reported in individuals with generalized anxiety disorder [32] and panic disorder [33].”
BackgroundHannibal, K. E., & Bishop, M. D. (2014) · Physical Therapy · doi:10.2522/ptj.20130597 · Cited by 729
Inflammation-associated depression: From serotonin to kynurenine
Dantzer, R., O’Connor, J. C., Lawson, M. A., & Kelley, K. W. (2011) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2010.09.012 · Cited by 726
Cortisol stress reactivity across psychiatric disorders: a systematic review and meta-analysis
Zorn, J. V., Schür, R. R., Boks, M. P., Kahn, R. S., Joëls, M., & Vinkers, C. H. (2017) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2016.11.036 · Cited by 697
Monk, C. S., Telzer, E. H., Mogg, K., Bradley, B. P., Mai, X., Louro, H. M. C., Chen, G., McClure-Tone, E. B., Ernst, M., & Pine, D. S. (2008) · Archives of General Psychiatry · doi:10.1001/archpsyc.65.5.568 · Cited by 682 · cited 2×
“Functional studies on generalized anxiety disorder patients have reported changes in activity of the amygdala [145,146], hippocampus [147], prefrontal cortex [146,148,149], frontal gyrus [150], anterior cingulate cortex [148,149,151], ventral tegmental area [152], thalamus [153], striatum, and insula [154].”
BackgroundD'Mello, C., Le, T., & Swain, M. G. (2009) · The Journal of Neuroscience · doi:10.1523/jneurosci.3567-08.2009 · Cited by 675
Etkin, A., Prater, K. E., Schatzberg, A. F., Menon, V., & Greicius, M. D. (2009) · Archives of General Psychiatry · doi:10.1001/archgenpsychiatry.2009.104 · Cited by 664
Brain-immune communication pathways
Quan, N., & Banks, W. A. (2007) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2007.05.005 · Cited by 626 · cited 3×
“On the other hand, kynurenic acid, which is reduced in inflammatory states, counteracts neurotoxicity [62].”
BackgroundInfluentialInflammation-Induced Anhedonia: Endotoxin Reduces Ventral Striatum Responses to Reward
Eisenberger, N. I., Berkman, E. T., Inagaki, T. K., Rameson, L. T., Mashal, N. M., & Irwin, M. R. (2010) · Biological Psychiatry · doi:10.1016/j.biopsych.2010.06.010 · Cited by 596
Amygdala Response to Fearful Faces in Anxious and Depressed Children
Thomas, K. M. (2001) · Archives of General Psychiatry · doi:10.1001/archpsyc.58.11.1057 · Cited by 582 · cited 2×
“Functional studies on generalized anxiety disorder patients have reported changes in activity of the amygdala [145,146], hippocampus [147], prefrontal cortex [146,148,149], frontal gyrus [150], anterior cingulate cortex [148,149,151], ventral tegmental area [152], thalamus [153], striatum, and insula [154].”
BackgroundStress and the HPA axis: role of glucocorticoids in alcohol dependence
Stephens, M. (2012) · Alcohol Research: Current Reviews · doi:10.35946/arcr.v34.4.11 · Cited by 571
Inflammation in Depression and the Potential for Anti-Inflammatory Treatment
Kohler, O., Krogh, J., Mors, O., & Eriksen Benros, M. (2016) · Current Neuropharmacology · doi:10.2174/1570159x14666151208113700 · Cited by 516 · cited 1×
“As stress-induced inflammatory conditions have repeatedly been suggested to underlie the pathophysiology of various psychiatric disorders, previous studies have investigated the possible therapeutic role of anti-inflammatory agents in conditions such as depression [158].”
BackgroundSleep Loss Activates Cellular Inflammatory Signaling
Irwin, M. R., Wang, M., Ribeiro, D., Cho, H. J., Olmstead, R., Breen, E. C., Martinez-Maza, O., & Cole, S. (2008) · Biological Psychiatry · doi:10.1016/j.biopsych.2008.05.004 · Cited by 467
Anxiety disorders and inflammation in a large adult cohort
Vogelzangs, N., Beekman, A. T. F., de Jonge, P., & Penninx, B. W. J. H. (2013) · Translational Psychiatry · doi:10.1038/tp.2013.27 · Cited by 458 · cited 1×
“C-reactive protein levels, which are increased following interleukin 6 secretion [49], were observed to be elevated in a large cohort of individuals diagnosed with panic disorder, agoraphobia, and generalized anxiety disorder [50].”
BackgroundAbnormal attention modulation of fear circuit function in pediatric generalized anxiety disorder
McClure, E. B., Monk, C. S., Nelson, E. E., Parrish, J. M., Adler, A., Blair, R. J. R., Fromm, S., Charney, D. S., Leibenluft, E., Ernst, M., et al. (2007) · Archives of General Psychiatry · doi:10.1001/archpsyc.64.1.97 · Cited by 431 · cited 2×
“Functional studies on generalized anxiety disorder patients have reported changes in activity of the amygdala [145,146], hippocampus [147], prefrontal cortex [146,148,149], frontal gyrus [150], anterior cingulate cortex [148,149,151], ventral tegmental area [152], thalamus [153], striatum, and insula [154].”
BackgroundThe Stressed CNS: When Glucocorticoids Aggravate Inflammation
Sorrells, S. F., Caso, J. R., Munhoz, C. D., & Sapolsky, R. M. (2009) · Neuron · doi:10.1016/j.neuron.2009.09.032 · Cited by 425 · cited 1×
“Excess cortisol increases mineralocorticoid receptor affinity, and when bound to the mineralocorticoid receptor, cortisol has proinflammatory effects [21].”
BackgroundNeural sensitivity to social rejection is associated with inflammatory responses to social stress
Slavich, G. M., Way, B. M., Eisenberger, N. I., & Taylor, S. E. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1009164107 · Cited by 418 · cited 1×
“Increases in interleukin 6 and tumor necrosis factor alpha were associated with laboratory-based stressors in healthy controls, with tumor necrosis factor alpha levels showing positive correlations with anterior cingulate and insula activities [101].”
BackgroundStatus of Glucocorticoid Alterations in Post‐traumatic Stress Disorder
Yehuda, R. (2009) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2009.04979.x · Cited by 409 · cited 1×
“Stress influences the hypothalamic–pituitary–adrenal axis and autonomic nervous system and ultimately the immune system, as chronic stress has been reported to lead to hypothalamic–pituitary–adrenal axis negative feedback disruption [7], enhanced sympathetic nervous system activity, and reduced parasympathetic nervous…”
BackgroundRadua, J., van den Heuvel, O. A., Surguladze, S., & Mataix-Cols, D. (2010) · Archives of General Psychiatry · doi:10.1001/archgenpsychiatry.2010.70 · Cited by 400 · cited 2×
“For panic disorder, changes in volumes of the frontal and orbitofrontal cortices [109–114], anterior cingulate cortex [109,112,115,116], amygdala [109,117–120], temporal lobe [110,111,120,121], parahippocampal gyrus [122], insula [109], basal ganglia [111,118], caudate [123,124], and brainstem [112,116,125] have been…”
BackgroundSingewald, N., Schmuckermair, C., Whittle, N., Holmes, A., & Ressler, K. J. (2015) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2014.12.004 · Cited by 390 · cited 1×
“These disorders are associated with exaggerated fear reactions to stimuli specific to each disorder in the absence of any actual danger [3].”
BackgroundMindfulness meditation for younger breast cancer survivors: A randomized controlled trial
Bower, J. E., Crosswell, A. D., Stanton, A. L., Crespi, C. M., Winston, D., Arevalo, J., Ma, J., Cole, S. W., & Ganz, P. A. (2015) · Cancer · doi:10.1002/cncr.29194 · Cited by 390
Interleukin-1β: A New Regulator of the Kynurenine Pathway Affecting Human Hippocampal Neurogenesis
Zunszain, P. A., Anacker, C., Cattaneo, A., Choudhury, S., Musaelyan, K., Myint, A. M., Thuret, S., Price, J., & Pariante, C. M. (2012) · Neuropsychopharmacology · doi:10.1038/npp.2011.277 · Cited by 388 · cited 1×
“Pro-inflammatory cytokines increase indoleamine 2,3-dioxygenase activity [95–97], and as a result more tryptophan degradation occurs through the kynurenine pathway, which increases the kynurenine/tryptophan ratio [98].”
BackgroundMind–body therapies and control of inflammatory biology: A descriptive review
Bower, J. E., & Irwin, M. R. (2016) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2015.06.012 · Cited by 388 · cited 1×
“Other behavioral interventions that have been shown to be effective in alleviating anxiety symptoms, such as yoga and meditation [159], have been suggested to do so by dampening inflammatory processes [160].”
BackgroundNeural Origins of Human Sickness in Interoceptive Responses to Inflammation
Harrison, N. A., Brydon, L., Walker, C., Gray, M. A., Steptoe, A., Dolan, R. J., & Critchley, H. D. (2009) · Biological Psychiatry · doi:10.1016/j.biopsych.2009.03.007 · Cited by 345 · cited 1×
“Enhanced interleukin 6 levels were accompanied by fatigue, confusion, and impaired concentration [106] and were reported to influence amygdala and subgenual anterior cingulate cortex connectivity [104].”
BackgroundBroad spectrum of cytokine abnormalities in panic disorder and posttraumatic stress disorder
Hoge, E. A., Brandstetter, K., Moshier, S., Pollack, M. H., Wong, K. K., & Simon, N. M. (2009) · Depression and Anxiety · doi:10.1002/da.20564 · Cited by 343
A pilot study of amygdala volumes in pediatric generalized anxiety disorder
De Bellis, M. D., Casey, B. J., Dahl, R. E., Birmaher, B., Williamson, D. E., Thomas, K. M., Axelson, D. A., Frustaci, K., Boring, A. M., Hall, J., et al. (2000) · Biological Psychiatry · doi:10.1016/s0006-3223(00)00835-0 · Cited by 322 · cited 2×
“Increased volumes were reported in the dorsomedial prefrontal cortex [140], amygdala [137,140], superior temporal gyrus [139], superior temporal pole, and basal ganglia [144].”
BackgroundThe kynurenine pathway and neurodegenerative disease
Maddison, D. C., & Giorgini, F. (2015) · Seminars in Cell & Developmental Biology · doi:10.1016/j.semcdb.2015.03.002 · Cited by 309 · cited 2×
“In the kynurenine pathway, kynurenine is formed when tryptophan 2,3-dioxygenase cleaves the indole-ring of tryptophan [89].”
BackgroundThe Effects of Mind-Body Therapies on the Immune System: Meta-Analysis
Morgan, N., Irwin, M. R., Chung, M., & Wang, C. (2014) · PLoS ONE · doi:10.1371/journal.pone.0100903 · Cited by 294 · cited 1×
“Although mixed effects were shown for the association between such interventions and circulating inflammatory markers [161], more consistent findings were seen for genomic markers, with trials showing decreased expression of inflammation-related genes and reduced signaling [162,163].”
BackgroundBower, J. E., Greendale, G., Crosswell, A. D., Garet, D., Sternlieb, B., Ganz, P. A., Irwin, M. R., Olmstead, R., Arevalo, J., & Cole, S. W. (2014) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2014.01.019 · Cited by 283 · cited 1×
“Although mixed effects were shown for the association between such interventions and circulating inflammatory markers [161], more consistent findings were seen for genomic markers, with trials showing decreased expression of inflammation-related genes and reduced signaling [162,163].”
BackgroundBlair, K., Shaywitz, J., Smith, B. W., Rhodes, R., Geraci, M., Jones, M., McCaffrey, D., Vythilingam, M., Finger, E., Mondillo, K., et al. (2008) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2008.07071060 · Cited by 282
Autonomic and Respiratory Characteristics of Posttraumatic Stress Disorder and Panic Disorder
Blechert, J., Michael, T., Grossman, P., Lajtman, M., & Wilhelm, F. H. (2007) · Psychosomatic Medicine · doi:10.1097/psy.0b013e31815a8f6b · Cited by 270 · cited 1×
“Increased sympathetic tone, decreased parasympathetic tone, and compromised vagal tone have all been described in panic disorder [44].”
BackgroundInflammation selectively enhances amygdala activity to socially threatening images
Inagaki, T. K., Muscatell, K. A., Irwin, M. R., Cole, S. W., & Eisenberger, N. I. (2012) · NeuroImage · doi:10.1016/j.neuroimage.2011.10.090 · Cited by 264
Association between adherence to the Mediterranean diet and oxidative stress
Dai, J., Jones, D. P., Goldberg, J., Ziegler, T. R., Bostick, R. M., Wilson, P. W., Manatunga, A. K., Shallenberger, L., Jones, L., & Vaccarino, V. (2008) · The American Journal of Clinical Nutrition · doi:10.3945/ajcn.2008.26528 · Cited by 256 · cited 1×
“Adherence to Mediterranean dietary patterns has also been suggested to improve anxiety symptoms [166], with Mediterranean diets being reported to modulate inflammatory processes [167].”
BackgroundBarrientos, R. M., Sprunger, D. B., Campeau, S., Higgins, E. A., Watkins, L. R., Rudy, J. W., & Maier, S. F. (2003) · Neuroscience · doi:10.1016/s0306-4522(03)00564-5 · Cited by 251
Muscatell, K. A., Dedovic, K., Slavich, G. M., Jarcho, M. R., Breen, E. C., Bower, J. E., Irwin, M. R., & Eisenberger, N. I. (2015) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2014.06.201 · Cited by 240
Propranolol for the treatment of anxiety disorders: Systematic review and meta-analysis
Steenen, S. A., van Wijk, A. J., van der Heijden, G. J., van Westrhenen, R., de Lange, J., & de Jongh, A. (2016) · Journal of Psychopharmacology · doi:10.1177/0269881115612236 · Cited by 237 · cited 1×
“Only a few systematic reviews on the effects of propranolol for the treatment of anxiety disorders have been conducted, with a recent meta-analysis reporting the quality of evidence for the efficacy of propranolol to be insufficient to support its routine use for the treatment of anxiety disorders [170].”
BackgroundRole of stress, corticotrophin releasing factor (CRF) and amygdala plasticity in chronic anxiety
Shekhar, A., Truitt, W., Rainnie, D., & Sajdyk, T. (2005) · Stress · doi:10.1080/10253890500504557 · Cited by 237
Network beyond IDO in psychiatric disorders: Revisiting neurodegeneration hypothesis
Myint, A.-M., & Kim, Y.-K. (2014) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2013.08.008 · Cited by 230
Self-citationMantella, R. C., Butters, M. A., Amico, J. A., Mazumdar, S., Rollman, B. L., Begley, A. E., Reynolds, C. F., & Lenze, E. J. (2008) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2008.03.002 · Cited by 222
Mochcovitch, M. D., da Rocha Freire, R. C., Garcia, R. F., & Nardi, A. E. (2014) · Journal of Affective Disorders · doi:10.1016/j.jad.2014.06.041 · Cited by 206 · cited 1×
“Recent neuroimaging techniques are detecting objective biological markers that reflect the pathophysiology of various psychiatric disorders [11].”
BackgroundEffect of beta blockade and beta stimulation on stage fright.
Brantigan, C. O., Brantigan, T. A., & Joseph, N. (1982) · The American Journal of Medicine · doi:10.1016/0002-9343(82)90592-7 · Cited by 178
Shang, J., Fu, Y., Ren, Z., Zhang, T., Du, M., Gong, Q., Lui, S., & Zhang, W. (2014) · PLoS ONE · doi:10.1371/journal.pone.0093432 · Cited by 164 · cited 1×
“Numerous studies have reported increased cytokine levels influence prefrontal and limbic structures [99], which are areas that have repeatedly been associated with anxiety disorders [100].”
BackgroundHPA axis response to a psychological stressor in generalised social phobia
Condren, R. (2002) · Psychoneuroendocrinology · doi:10.1016/s0306-4530(01)00070-1 · Cited by 155
Krain, A. L., Gotimer, K., Hefton, S., Ernst, M., Castellanos, F. X., Pine, D. S., & Milham, M. P. (2008) · Biological Psychiatry · doi:10.1016/j.biopsych.2007.06.011 · Cited by 147 · cited 2×
“Functional studies on generalized anxiety disorder patients have reported changes in activity of the amygdala [145,146], hippocampus [147], prefrontal cortex [146,148,149], frontal gyrus [150], anterior cingulate cortex [148,149,151], ventral tegmental area [152], thalamus [153], striatum, and insula [154].”
BackgroundGeneralized anxiety and C-reactive protein levels: a prospective, longitudinal analysis
Copeland, W. E., Shanahan, L., Worthman, C., Angold, A., & Costello, E. J. (2012) · Psychological Medicine · doi:10.1017/s0033291712000554 · Cited by 123
Enhanced Th17 phenotype in individuals with generalized anxiety disorder
Vieira, M. M. M., Ferreira, T. B., Pacheco, P. A. F., Barros, P. O., Almeida, C. R. M., Araújo-Lima, C. F., Silva-Filho, R. G., Hygino, J., Andrade, R. M., Linhares, U. C., et al. (2010) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2010.07.018 · Cited by 118
Ida, T., Hara, M., Nakamura, Y., Kozaki, S., Tsunoda, S., & Ihara, H. (2008) · Neuroscience Letters · doi:10.1016/j.neulet.2007.12.047 · Cited by 107
Bankier, B., Barajas, J., Martinez-Rumayor, A., & Januzzi, J. L. (2008) · European Heart Journal · doi:10.1093/eurheartj/ehn326 · Cited by 102
Kullmann, J. S., Grigoleit, J.-S., Lichte, P., Kobbe, P., Rosenberger, C., Banner, C., Wolf, O. T., Engler, H., Oberbeck, R., Elsenbruch, S., et al. (2013) · Human Brain Mapping · doi:10.1002/hbm.22063 · Cited by 93 · cited 1×
“Increased levels of tumor necrosis factor alpha, interleukin 1, and interleukin 6 were reported after bacterial lipopolysaccharide injections, accompanied by an increased state of anxiety and orbitofrontal cortex activation in response to emotional visual stimuli [102].”
BackgroundWingo, A. P., & Gibson, G. (2015) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2014.09.016 · Cited by 59 · cited 1×
“Increased tumor necrosis factor alpha levels have also been reported in generalized anxiety disorder patients [53], and genetic studies have reported patients with generalized anxiety disorder show alterations in immune-related gene expression [56].”
BackgroundThe significance of HPA axis disturbance in panic disorder
Coryell, W., Noyes, R., & Schlechte, J. (1989) · Biological Psychiatry · doi:10.1016/0006-3223(89)90287-4 · Cited by 47 · cited 1×
“Increased cortisol awaking response and cortisol non-suppression in response to dexamethasone have been reported in patients with agoraphobia and panic disorder [34,35].”
BackgroundCirculating Lymphocyte Phenotypic Surface Markers in Anxiety Disorder Patients and Normal Volunteers
Rapaport, M. H. (1998) · Biological Psychiatry · doi:10.1016/s0006-3223(97)00263-1 · Cited by 43
Wagner, E.-Y. N., Wagner, J. T., Glaus, J., Vandeleur, C. L., Castelao, E., Strippoli, M.-P. F., Vollenweider, P., Preisig, M., & von Känel, R. (2015) · PLOS ONE · doi:10.1371/journal.pone.0123757 · Cited by 40
Cited by
How inflammation affects the brain in depression: a review of functional and structural MRI studies
Han, K.-M., & Ham, B.-J. (2021) · Journal of Clinical Neurology · doi:10.3988/jcn.2021.17.4.503 · Cited by 187
Alzheimer’s Disease: Exploring the Landscape of Cognitive Decline
Tenchov, R., Sasso, J. M., & Zhou, Q. A. (2024) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.4c00339 · Cited by 170
Lee, S. (2026) · Toxicology Mechanisms and Methods · doi:10.1080/15376516.2025.2584495 · Cited by 8
Metadata
- Authors
- Won, E., & Kim, Y.-K.
- Venue
- International Journal of Molecular Sciences
- Publisher
- MDPI AG
- Published
- 2020-09-07
- Volume
- 21
- Issue
- 18
- Pages
- 6546
- ISSN
- 1422-0067 (ISSN-L)
- OpenAlex
- W3083389210
- Cited by
- 178
- References
- 69
- FWCI
- 2.42
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.